FIELD: medicine, pharmaceutics.
SUBSTANCE: there are described fumaryl diketopiperazin (FDKP) formulations and microparticles with the particular amount of trans-isomer making approximately 45% to approximately 65%. The FDKP microparticles can contain a drug such as endocrine hormone including a peptide, including insulin, glucagon, parathyroid hormone, and can be used to prepare a powder for pulmonary drug delivery.
EFFECT: fumaryl diketopiperazin (FDKP) microparticles with the above amount of trans-isomer show the improved aerodynamic properties.
27 cl, 6 dwg, 6 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
SYSTEMS AND METHODS FOR DRY POWDER DRUG DELIVERY | 2011 |
|
RU2571331C1 |
SYSTEMS AND METHODS FOR DRY POWDER DRUGS DELIVERY | 2011 |
|
RU2531455C2 |
DRY POWDER DRUG DELIVERY SYSTEMS AND METHODS | 2013 |
|
RU2650035C2 |
INHALER FOR DRY POWDER AND SYSTEM FOR DRUG DELIVERY | 2016 |
|
RU2731107C2 |
DRY POWDER INHALER AND DRUG DELIVERY SYSTEM | 2009 |
|
RU2468832C2 |
DRY POWDER INHALER AND DRUG DELIVERY SYSTEM | 2009 |
|
RU2608439C2 |
ADVANCED DRY POWDER DELIVERY SYSTEM | 2010 |
|
RU2487731C2 |
DIKETOPIPERAZINE MICROPARTICLES WITH PARTICULAR SPECIFIC SURFACE AREAS | 2010 |
|
RU2509555C2 |
METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
ACTIVE SUBSTANCE DELIVERY | 2008 |
|
RU2467741C2 |
Authors
Dates
2013-08-20—Published
2010-06-11—Filed